IL6 and cancer: Cancer cells produce soluble factors, such as cytokines—for example, interleukin-6 (IL-6), IL-11, tumor necrosis factor alpha (TNF-α), and receptor activator of nuclear factor kappa-Β ligand (RANKL)—that activate osteoclastogenesis, leading to bone degradation.